If you’re living with an arthritic condition
or trying to recover from joint surgery, you should take a keener interest in
Arthronica. It is a digital health tech start-up that was spun-out from the
bioengineering department of Imperial College London in 2018. Progress since
then has been swift. It was recently selected as one of the top 10
cutting-edge, London-based, women-led businesses picked to present at
TechInvest in June as part of London Tech Week 2020.
In terms of its product, Arthronica deploys artificial Intelligence for patient monitoring and rehabilitation in a bid to reduce chronic pain and support doctors in the diagnosis and treatment of arthritic conditions.
Arthronica enables you to get support for chronic join inflammation with tailored exercises and medication reminders while visualising your progress throughout treatment. Recovery can be optimised after joint surgery via remote consultations with your doctor to check your progress.
Rheumatologists can remotely check how patients are responding to treatments, while physiotherapists and surgeons can provide online support to optimise their patient’s recovery. In addition, Arthronica supports drug delivery and development as it has a companion diagnostic software function.
So far, Arthronica has won funding support
from Research England, Entrepreneur First, an international talent Investor
scheme which supports individuals to build technology companies, and the
Johnson & Johnson Innovation Centre.